Jiajun Wu

1 Minde Road
Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.

Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.

Journal: Frontiers in oncology

Published: February 26, 2025

Causal Relationships Between Immune Cell Traits, Plasma Metabolites, and Asthma: A Two-Step, Two-Sample Mendelian Randomization Study.

Causal Relationships Between Immune Cell Traits, Plasma Metabolites, and Asthma: A Two-Step, Two-Sample Mendelian Randomization Study.

Journal: The clinical respiratory journal

Published: February 17, 2025

Identification and validation of a novel signature based on immune‑related genes from epithelial cells to predict prognosis and treatment response in patients with lung squamous cell cancer by integrated analysis of single‑cell and bulk RNA sequencing.

Identification and validation of a novel signature based on immune‑related genes from epithelial cells to predict prognosis and treatment response in patients with lung squamous cell cancer by integrated analysis of single‑cell and bulk RNA sequencing.

Journal: Oncology letters

Published: August 28, 2024

Causal relationships between immune cells, plasma metabolites and lung adenocarcinoma: a two-step, two-sample Mendelian randomization study.

Causal relationships between immune cells, plasma metabolites and lung adenocarcinoma: a two-step, two-sample Mendelian randomization study.

Journal: Journal of Cancer

Published: August 24, 2024

Integrated analysis of single‑cell and bulk RNA sequencing data to construct a risk assessment model based on plasma cell immune‑related genes for predicting patient prognosis and therapeutic response in lung adenocarcinoma.

Integrated analysis of single‑cell and bulk RNA sequencing data to construct a risk assessment model based on plasma cell immune‑related genes for predicting patient prognosis and therapeutic response in lung adenocarcinoma.

Journal: Oncology letters

Published: August 19, 2024

Identification and Validation of a Prognostic Signature Based on Fibroblast Immune-related Genes to Predict the Prognosis and Therapeutic Response of renal clear cell carcinoma by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data.

Identification and Validation of a Prognostic Signature Based on Fibroblast Immune-related Genes to Predict the Prognosis and Therapeutic Response of renal clear cell carcinoma by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data.

Journal: Journal of Cancer

Published: June 27, 2024

Mendelian Randomization Analysis of Non-small Cell Lung Cancer and Five Exposure Factors Based on Pathway Enrichment Analysis.

Mendelian Randomization Analysis of Non-small Cell Lung Cancer and Five Exposure Factors Based on Pathway Enrichment Analysis.

Journal: Journal of Cancer

Published: May 22, 2024

Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data.

Identification Of Endothelial Cell Immune-related Gene Signature for Lung Adenocarcinoma by Integrated Analysis of Single-cell and Bulk RNA Sequencing Data.

Journal: Journal of Cancer

Published: January 20, 2024

Machine learning predictive models and risk factors for lymph node metastasis in non-small cell lung cancer.

Machine learning predictive models and risk factors for lymph node metastasis in non-small cell lung cancer.

Journal: BMC pulmonary medicine

Published: November 21, 2023

Gefitinib metabolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma.

Gefitinib metabolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma.

Journal: Scientific reports

Published: October 27, 2023

Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.

Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.

Journal: PloS one

Published: October 27, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026